News

Santé log1h
Idorsia publishes interim results of repurchase offer for its 2025 and 2028 convertible bonds
Idorsia Ltd (SIX: IDIA) announces the interim results of the repurchase offer for its outstanding CHF 204 * million convertible bonds maturing in 2025 (CB 2025; ISIN CH0426820350) and CHF 600 million ...
Santé log1h
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
Announced on August 8, 2025, that the U.S. Food and Drug Administration (FDA) has approved the Genio® system for a subset of adult patients with moderate to severe OSA with an Apnea-Hypopnea Index ...
Santé log2d
Folqs Highlights First-Day, Grass-Fed Colostrum Powder Amid Global Surge in Demand
Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Folqs, a U.S.-based wellness company, introduces new consumer product, ...
Santé log2d
NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard
Importantly, these exosomes were produced from NurExone’s proprietary master cell bank, whose cells are maintained under ...
Santé log2d
Heartland Physio Unveils The R.E.A.L. Recovery Experience for Singapore’s Active Professionals
Singapore, Singapore, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Heartland Physio is proud to unveil its signature R.E.A.L. Recovery™ ...
Santé log2d
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
The test, based on immunochromatographic technology, enables reliable qualitative detection of Chikungunya-specific antibodies in human serum, plasma, or whole blood. This addition strengthens Anbio’s ...
Santé log3d
Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital
Longeviti Neuro Solutions, a neurotechnology company with a focus on innovative platform solutions for complex brain ...
Santé log2d
XORTX Completes USD $114,500 Private Placement
XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout ...
Santé log2d
REPEAT - Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announced an update on institutional ownership of the Company’s outstanding ...
Santé log2d
Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test
The SmartVascular Dx test is essential for the early detection of vascular disease, which is a significant health concern in many communities. Its capabilities enable timely and targeted interventions ...
Santé log3d
Annovis Completes Full Patent Transfer to Crystal Buntanetap
Annovis achieves comprehensive intellectual property (IP) protection now covering both the original semi-crystalline and new ...
Santé log2d
Amwell makes grant to new employees under inducement plan
The grants described in this press release were approved by the Compensation Committee of the Amwell’s Board of Directors pursuant to the Amwell’s Inducement Plan and made in reliance on the ...